Ofatumumab Intravenous and Rabeprazole Delayed-Release Tablets
Determining the interaction of Ofatumumab Intravenous and Rabeprazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ofatumumab
Brand name: Arzerra
Synonyms: Ofatumumab
Generic Name: rabeprazole
Brand name: Aciphex, AcipHex Sprinkle
Synonyms: Rabeprazole, RABEprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ofatumumab Intravenous-Rabeprazole Sodium
- Ofatumumab Intravenous-Rabeprazole Sprinkle Capsules
- Ofatumumab Intravenous-Rabies Immune Globulin
- Ofatumumab Intravenous-Rabies immune globulin human
- Ofatumumab Intravenous-Rabies immune globulin Intramuscular
- Ofatumumab Intravenous-Rabies Vaccine
- Rabeprazole Delayed-Release Tablets-Ofev
- Rabeprazole Delayed-Release Tablets-Off-Ezy Topical
- Rabeprazole Delayed-Release Tablets-Ofirmev
- Rabeprazole Delayed-Release Tablets-Ofloxacin
- Rabeprazole Delayed-Release Tablets-Ofloxacin (Systemic)
- Rabeprazole Delayed-Release Tablets-Oforta